Counterfeit Mounjaro Drug Operation Exposed in Gurugram
Different packaging, typos expose fake Mounjaro racket
The Economic Times
Image: The Economic Times
Authorities in Gurugram, Haryana, India, have uncovered a counterfeit operation involving Mounjaro injections, a diabetes and weight loss drug. The operation, led by Avi Sharma, used raw materials sourced from China, resulting in fake products with significant packaging discrepancies. A raid on April 18 led to the seizure of counterfeit injections valued at ₹70 lakh (approximately $84,000 USD).
- 01Counterfeit Mounjaro injections were produced in a flat in Gurugram.
- 02The operation was led by Avi Sharma, who sought to increase his income.
- 03Authorities seized fake injections worth ₹70 lakh (approximately $84,000 USD).
- 04Packaging differences included color discrepancies and typographical errors.
- 05Eli Lilly, the manufacturer of Mounjaro, has expressed concern over the counterfeit products.
Advertisement
In-Article Ad
In Gurugram, Haryana, India, a counterfeit drug operation involving Mounjaro (tirzepatide) injections was exposed by the Drugs Control Office. The operation was led by Avi Sharma, who allegedly sourced raw materials from China via Alibaba. Authorities conducted a raid on April 18, seizing fake injections valued at ₹70 lakh (approximately $84,000 USD) from a vehicle in DLF Phase 4. Investigators noted significant differences in packaging, including color discrepancies and typographical errors, which helped identify the counterfeit products. Following the initial arrests, including that of a deliveryman named Mujjamil, Sharma was apprehended for producing the fake injections in a flat in Gurugram's Sector 62. Eli Lilly, the American pharmaceutical company that manufactures Mounjaro, has acknowledged the seizure and emphasized the importance of patient safety.
Advertisement
In-Article Ad
The exposure of this counterfeit operation highlights the risks associated with fake medications, which can endanger patients' health and undermine trust in legitimate pharmaceutical products.
Advertisement
In-Article Ad
Reader Poll
How concerned are you about counterfeit medications in the market?
Connecting to poll...
More about Eli Lilly
New Procedure Shows Promise in Sustaining Weight Loss for Type 2 Diabetes Patients
The Economic Times • Apr 25, 2026
JPMorgan inicia cobertura de Hims & Hers con calificación positiva y precio objetivo de $35
Investing • Apr 24, 2026
Amazon startet Verkauf von Abnehmspritzen in den USA
Bild • Apr 22, 2026
Read the original article
Visit the source for the complete story.